The following is a physician-patient interaction that took place within TheBody.com's "Ask the Experts" forum on hepatitis.
|Types and Stages of Hep-C. What are they ?
Feb 23, 2013
What is Type-II, Stage-II? Explain what this means. I have this diagnosis and I have done the Interferon Pagesys treatment. I could not get my counts to come down to undetectable.
| Response from Dr. Taylor
The types of hepatitis C refer to the strains, or variations, of the virus. These are called genotypes. I think of these like flavors of ice cream -- chocolate, vanilla, coffee, mango, green tea -- there are different flavors of hep C. The genotype you have comes from the genotype you caught when you caught hep C. The treatments for hep C vary depending on the genotype. Both the particular medications and duration of treatment can be affected by one's genotype. In general we think of genotypes 1 through 6 with subtypes noted by letters, for example 1a 1b 1c. Genotypes are clustered around the world in different ways. For example, in the U.S. 75% of people have type 1. In Europe, more people have genotypes 2 and 3.
Stage refers to how much scarring is in the liver. There are several different staging systems. The higher the number, the more the scarring. I would ask your doctor what staging system she/he uses, for example 1-6 or 1-4.
Return to our full listing of answers to patients' frequently asked questions regarding hepatitis C transmission, testing, management and treatment.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Conversations on Viral Suppression and HIV Transmission, Social Media and HIV, and an Update on PACHA From the 2017 U.S. Conference on AIDS|
|Guidance for Providers Treating HIV-Positive People Displaced by Hurricane Harvey|
|This Week in HIV Research: Injectable PrEP Shows Promise in New Study|
|Million in Funding to Help HIV Organizations Impacted by Hurricanes Harvey and Irma Announced at USCA|
|Heavy Marijuana Use Tied to Midlife Cardiovascular Events in U.S. Men With HIV|
|Conversations With Federal HIV Leaders From the 2017 U.S. Conference on AIDS|